BioWorld

Aug. 8, 2005

View Archived Issues

Anadys Raises $62M To Advance Early Programs

Two months ago, when Anadys Pharmaceuticals Inc. signed what might be the largest Phase I deal in biotech history, the company's CEO said Anadys wouldn't need to do a financing for at least two years. (BioWorld Today) Read More

Neose Reduces Work Force 25 Percent In Restructuring

Read More

FDA Raises Drug Application Costs For Coming Fiscal Year

Read More

Advanced Life Sciences Gets $32M In Lethargic IPO Market

Read More

Other News To Note

Read More